Literature DB >> 24425668

Changing etiologies and outcomes of acute liver failure: perspectives from 6 transplant centers in Argentina.

Manuel Mendizabal1, Sebastián Marciano, María G Videla, Margarita Anders, Alina Zerega, Domingo C Balderramo, Débora Chan, Martín Barrabino, Octavio Gil, Ricardo Mastai, Silvina Yantorno, Adrián Gadano, Marcelo O Silva.   

Abstract

There is significant geographic variation in the etiologies and prognoses of acute liver failure (ALF). The aims of the present study were to determine the causes and short-term outcomes of ALF in Argentina, to evaluate the performance of prognostic criteria, and to identify clinical prognostic factors of death. We performed a retrospective analysis of 154 adult patients with ALF who were admitted to 6 liver transplantation (LT) programs between June 2005 and December 2011. The most frequent causes of ALF were viral hepatitis B (46 patients or 30%), autoimmune hepatitis (AIH; 40 patients or 26%), and indeterminate causes (40 patients or 26%). No acetaminophen (ACM) overdose was reported. One hundred and twenty one patients (78%) were included on the waiting list, and LT was performed for 83 patients (54%). Overall survival rate is now corected to 73%. Multivariate logistic regression identified 2 independent variables associated with adverse outcomes on admission: a Model for End-Stage Liver Disease (MELD) score ≥ 29 and an encephalopathy grade ≥ 3. In a direct comparison using a receiving operating characteristic curve analysis, the MELD score [C statistic = 0.830, 95% confidence interval (CI) = 0.73-0.93] had better prognostic accuracy for predicting outcomes than the Clichy criteria (C statistic = 0.719, 95% CI = 0.58-0.85) or the King's College criteria (C statistic = 0.631, 95% CI = 0.49-0.77). In conclusion, hepatitis B and AIH were the most frequent causes of fulminant hepatic failure in our series, and no cases of ACM overdosing were identified. A MELD score ≥ 29 and an encephalopathy grade ≥ 3 at admission were associated with death. The MELD score at admission showed the highest prognostic accuracy.
© 2014 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2014        PMID: 24425668     DOI: 10.1002/lt.23823

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  8 in total

1.  Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients.

Authors:  Aiman Obed; Steffen Stern; Anwar Jarrad; Thomas Lorf
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

2.  Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system.

Authors:  David S Goldberg; Kimberly A Forde; Dena M Carbonari; James D Lewis; Kimberly B F Leidl; K Rajender Reddy; Kevin Haynes; Jason Roy; Daohang Sha; Amy R Marks; Jennifer L Schneider; Brian L Strom; Douglas A Corley; Vincent Lo Re
Journal:  Gastroenterology       Date:  2015-02-28       Impact factor: 22.682

Review 3.  Liver transplantation in acute liver failure: A challenging scenario.

Authors:  Manuel Mendizabal; Marcelo Oscar Silva
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

4.  Acute Liver Failure of Indeterminate Etiology: A Comprehensive Systematic Approach by An Expert Committee to Establish Causality.

Authors:  Daniel R Ganger; Jody Rule; Jorge Rakela; Nathan Bass; A Reuben; R T Stravitz; Norman Sussman; Anne M Larson; Laura James; Charles Chiu; William M Lee
Journal:  Am J Gastroenterol       Date:  2018-06-27       Impact factor: 12.045

5.  Autoimmune Hepatitis-related Cirrhosis: Clinical Features and Effectiveness of Immunosuppressive Treatment in Chinese Patients.

Authors:  Yan-Ni Li; Huan Ma; Lu Zhou; Jie Zhang; Li-Ping Guo; Shu-Qian Li; Yi-Qi Qian; Bang-Mao Wang
Journal:  Chin Med J (Engl)       Date:  2016-10-20       Impact factor: 2.628

6.  A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases.

Authors:  Bertrand Nalpas; Philippe Ichaï; Laure Jamot; Nicolas Carbonell; Marika Rudler; Philippe Mathurin; François Durand; Guido Gerken; Michael Manns; Christian Trautwein; Dominique Larrey; Sylvie Radenne; Christophe Duvoux; Vincent Leroy; Jacques Bernuau; Jamila Faivre; Nicolas Moniaux; Christian Bréchot; Gilles Amouyal; Paul Amouyal; Didier Samuel
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

Review 7.  The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative.

Authors:  Fernando Bessone; Nelia Hernandez; M Isabel Lucena; Raúl J Andrade
Journal:  Int J Mol Sci       Date:  2016-02-29       Impact factor: 5.923

8.  Systematic review of the global epidemiology of viral-induced acute liver failure.

Authors:  Jenna Patterson; Hannah Sophia Hussey; Sheetal Silal; Liz Goddard; Mashiko Setshedi; Wendy Spearman; Gregory D Hussey; Benjamin M Kagina; Rudzani Muloiwa
Journal:  BMJ Open       Date:  2020-07-20       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.